| Cheyenne Cierria Godwin, PHARMD | |
|
847 Boll Weevil Cir Ste 112, Enterprise, AL 36330-2476 | |
| (334) 348-1526 | |
| Not Available |
| Full Name | Cheyenne Cierria Godwin |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 847 Boll Weevil Cir Ste 112, Enterprise, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699261768 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 20430 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cheyenne Cierria Godwin, PHARMD 409 Dixie Dr, Enterprise, AL 36330-2120 Ph: (334) 806-2557 | Cheyenne Cierria Godwin, PHARMD 847 Boll Weevil Cir Ste 112, Enterprise, AL 36330-2476 Ph: (334) 348-1526 |
News Archive
Alexza Pharmaceuticals, Inc. announced today that it has licensed its Staccato nicotine technology to Cypress Bioscience, Inc. The Staccato nicotine technology is a novel electronic multidose delivery system designed to help people stop smoking. The Staccato nicotine technology is intended to improve on a well-validated smoking cessation approach by delivering nicotine via inhalation, mimicking the nicotine effects of smoking without the harmful side effects associated with cigarettes.
The data from the initial clinical studies with KB001, a novel antibody fragment against PcrV on Pseudomonas aeruginosa (Pa) bioengineered by KaloBios Pharmaceuticals, Inc. and partnered with sanofi pasteur, demonstrated promising therapeutic activity in the prevention of serious lung infection in mechanically ventilated patients colonized with the bacterium and in limiting potentially damaging inflammation in patients with cystic fibrosis, where Pa plays an important role in the disease.
Nanotherapeutics, Inc. announced that it has been awarded a contract by the U.S. Department of Defense to support a clinical trial for treating dehisced surgical wounds with the Company's NanoDOX Hydrogel, a topical doxycycline hydrogel for chronic wounds.
The new limits on hours that physicians-in-training can work will prove costly for U.S teaching hospitals, which will need to spend up to $1.3 billion a year, and possibly more, to effect the changes, a new UCLA study suggests.
› Verified 3 days ago
Joseph Paul Russell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 204 E Brunson St, Enterprise, AL 36330 Phone: 334-347-6865 Fax: 334-393-0679 | |
Christine Anne Mcculley, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 N Edwards St, Enterprise, AL 36330 Phone: 334-347-1202 | |
Dr. Michele L Garrett Iv, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 900 Fort Rucker Blvd, Enterprise, AL 36330 Phone: 334-393-1348 | |
Mr. Gregory Larkin Goodson, NRPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 612 N Main St, Suite A, Enterprise, AL 36330 Phone: 334-393-0086 Fax: 334-393-0206 | |
Gladys Theiler, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 900 Rucker Blvd, Enterprise, AL 36330 Phone: 334-393-1348 Fax: 393-393-1386 | |
Cheryl Massey, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 903 Rucker Blvd, Enterprise, AL 36330 Phone: 334-393-4440 Fax: 334-393-2449 | |
Natasha Lynn Rosekrans, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 850 Boll Weevil Cir, Enterprise, AL 36330 Phone: 334-389-3143 |